RecruitingNot ApplicableNCT04824053

Effects of UNICLA-A2 Dairy Products on Patients At High-risk of Colorectal Cancer Development

Comparative Analysis of the Effects of UNICLA-A2 Against Conventional Dairy Products Administered Daily in Patients At High-risk Colorectal Cancer Development Who Have Undergone Polypectomy


Sponsor

Instituto de Investigación Sanitaria Aragón

Enrollment

34 participants

Start Date

Feb 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Dietary intervention with UNICLA-A2 milk products containing beta casein A2 protein, and higher levels of omega-3 fatty acids and selenium may contribute to maintain the intestinal integrity, reduce inflammatory processes, normalize the immune system, protect against oxidative damage and equilibrate the gut microbiota in high-risk colorectal cancer patients who have undergone polypectomy


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria11

  • Participants diagnosed with high-risk polyps in the colorectal cancer screening programme or in the relative's colon cancer prevention program or patients who are in follow-up due to prior detection of polyps with any of the following characteristics:
  • At least 10 adenomas
  • At least 5 proximal serrated polyps (PSP)
  • At least 2 serrated polyps with diameters ≥10 mm
  • Serrated Polyposis Syndrome (SPS)
  • Early invasive CRC (stage pT1) endoscopically resected (surgery not required)
  • A sessile or flat lesion ≥ 20 mm with fragmented resection
  • Patients with previous resection of polyps in which the resection margin was not assessable and are considered susceptible to repeat colonoscopy
  • Patients with intramucosal carcinoma in situ or invasion of the lamina propria (pTis)
  • Regular consumer of milk and dairy products.
  • Informed consent form signed.

Exclusion Criteria5

  • History of allergic reaction attributed to compounds of similar chemical composition to the study agents.
  • Incomplete colonoscopy or with poor quality criteria, Boston \<6.
  • Concomitant acetylsalicylic acid (ASA), NSAIDs, misoprostol, corticosteroids or statins needed on a regular or predictable basis during the time of the study.
  • Previous gastrointestinal surgery (colon or small intestine or gastric) that affects the absorption of nutrients.
  • History of familial adenomatous polyposis.

Interventions

DIETARY_SUPPLEMENTMilk from genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of 250 mL of milk. The intervention duration will be 3 months

DIETARY_SUPPLEMENTConventional milk

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of 250 mL of milk. The intervention duration will be 3 months

DIETARY_SUPPLEMENTYogurt made from milk of genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of one yogurt. The intervention duration will be 3 months

DIETARY_SUPPLEMENTConventional yogurt

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of one yogurt. The intervention duration will be 3 months

DIETARY_SUPPLEMENTFresh cheese made from milk of genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of 50 g of fresh cheese. The intervention duration will be 3 months

DIETARY_SUPPLEMENTConventional fresh cheese

The daily intake should reflect habitual consumption habits in "real life" conditions, without forcing or inducing greater consumption. Therefore, patients will be recommended a daily intake of 50 g of fresh cheese. The intervention duration will be 3 months


Locations(1)

Angel Lanas Arbeloa

Zaragoza, Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04824053


Related Trials